- Global Pharma News & Resources

Odile Bain Memorial Prize 2021: Brilliant early-career scientists in parasitology recognized

  • Researchers in the field of parasitology celebrated for contributions early in their scientific careers
  • Together with scientific publisher Parasites & Vector, Boehringer Ingelheim has sponsored the award since its founding in 2014
  • Award serves to foster career growth in parasitology as well as keep memory of parasitologist Odile Bain alive

Ingelheim, Germany, July 21, 2021 – To celebrate outstanding contributions in the field of parasitology early on in their scientific careers, Dr Goylette Chami, University of Oxford, UK, and Dr Barbora Pafčo from the Czech Academy of Sciences and University of Veterinary Sciences, Brno, were awarded with the Odile Bain Memorial Prize 2021. Since 2014, The 'Odile Bain Memorial Prize' (OBMP) is given out annually under the sponsorship of Boehringer Ingelheim Animal Health as well as the scientific publisher Parasites & Vectors

“The award serves to advance young parasitologists as well as to perpetuate the memory of Odile Bain1, a pioneer in the field of parasitology,” explains Prof Domenico Otranto, President WAAVP (World Association for the Advancement of Veterinary Parasitology). In a virtual ceremony during the WAAVP Dublin 2021 congress on July 20, he handed the prize over.

An epidemiological perspective on parasitology – Goylette Chami

Goylette Chami's research interests concern improving the treatment of parasitic worms in sub-Saharan Africa. Her excellent work significantly contributed to the study of mass drug administration (MDA) through pioneering network graphing for evaluating MDA and neglected tropical diseases. In addition, Goylette Chami’s studies on key social determinants of persistent schistosomiasis (an “acute and chronic disease caused by parasitic worms,” according to the World Health Organization2) and hookworm infection have been particularly appreciated for their impact on marginalized individuals. “I plan to put my prize money towards researching how we can relate schistosome exposure over an individual's life to disease progression,” says Goylette Chami. 

Focus on strongylid nematodes – Barbora Pafčo

Barbora Pafčo’s work is focused on studying strongylid nematodes, recently shedding light on the factors leading to gastritis caused by parasitic nematodes in mountain gorillas. She has also been studying strongylid nematodes in cattle in the Czech Republic and the worldwide distribution of nematodes of the genus Necator, with implications for the potential of drug resistance and zoonotic risk. She is interested in parasite ecology, host-parasite relationship, and molecular diversity of pathogens. Barbora Pafčo shares: “Among other things, receiving the Odile Bain Memorial Prize shows me that my contributions are valued, which motivates me even more to strive for excellence.”  

Following in the footsteps of Odile Bain

The two winners receive a cash prize each. Additionally, they may participate in the WAAVP Dublin 2021 congress at no cost to benefit from learning and networking opportunities. The winners further receive a waiver of the charges for the publication of one article in Parasites & Vectors. Marielle Servonnet, Global Technical Director Pet Parasiticides Boehringer Ingelheim, adds: “We’re excited to see what Goylette Chami and Barbora Pafčo will be doing next and are proud to contribute towards supporting their research through this prize.” 

About the World Association for the Advancement of Veterinary Parasitology (WAAVP)

The World Association for the Advancement of Veterinary Parasitology (WAAVP) is a not-for-profit organization for scientists who study the parasites of non-human animals, encompassing helminthology, protozoology and entomology. More:

Boehringer Ingelheim Animal Health

The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. Across the globe, our 9,700 employees are dedicated to delivering value through innovation, thus enhancing the well-being of both.

Respect for animals, humans and the environment is at the heart of what we do. We develop solutions and provide services to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society-threatening diseases.

Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of 4.1 billion euros in 2020 and presence in more than 150 countries. For more information visit:

Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at

Editor Details

Related Links

Last Updated: 21-Jul-2021